Rhabdomyosarcoma other imaging findings
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Overview
Positron emission tomography (PET) scanning and bone scan are usually used for assessment of metastatic lesion in rhabdomyosarcoma. There are no associated findings regarding these studies in rhabdomyosarcoma.
Other Imaging Findings
Other Imaging Findings
- There are some other diagnosis methods for rhabdomyosarcoma evaluation:
Positron emission tomography (PET) scanning
- No particular findings associated with rhabdomyosarcom
- Assessment of patient’s respond to therapy[1][2]
- Assessment of distant metastases which were unidentified by other imaging studies
Bone Scan
- Assessment of metastases to bones[3]
- Evaluation of whole skeleton
References
References
- ↑ McCarville MB, Christie R, Daw NC, Spunt SL, Kaste SC (2005). “PET/CT in the evaluation of childhood sarcomas”. AJR Am J Roentgenol. 184 (4): 1293–304. doi:10.2214/ajr.184.4.01841293. PMID 15788613.
- ↑ Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M; et al. (2007). “Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial”. J Clin Oncol. 25 (34): 5435–41. doi:10.1200/JCO.2007.12.2473. PMID 18048826.
- ↑ Weiss AR, Lyden ER, Anderson JR, Hawkins DS, Spunt SL, Walterhouse DO; et al. (2013). “Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children’s Oncology Group Soft Tissue Sarcoma Committee”. J Clin Oncol. 31 (26): 3226–32. doi:10.1200/JCO.2012.44.6476. PMC 3757291. PMID 23940218.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH